User login
Catching up with our CHEST Past Presidents
Where are they now? What have they been up to? CHEST’s Past Presidents each forged the way for the many successes of the American College of Chest Physicians, leading to enhanced patient care around the globe. Their outstanding leadership and vision are evidenced today in many of CHEST’s strategic initiatives. Let’s check in with our first woman President, Dr. Deborah Shure.
Deborah Shure, MD, Master FCCP
President 1995-1996
When I began my year as President of the American College of Chest Physicians in 1995 in New York City, I became the first woman to serve in that role in the then 60-year history of the College. One major theme for my presidential year was inclusiveness. With the support of the Regents and the members of the College, we sought to increase the roles of our International Fellows and Affiliate Members, as well as the participation of all of our FCCPs. We also expanded the role of the College in global tobacco control.
With a focus on these goals, the presidential year was truly an exciting and fulfilling one. I was honored to meet so many members worldwide and, through the College, enable the support of regional meetings internationally. Our efforts in the Asia-Pacific area lent essential support to one of the early conferences on tobacco control in the Philippines (Asia Pacific Conference on Control of Tobacco, Subic, Philippines, 1998). My presentation in 1996 in Bangkok was the College’s first International Partnering for World Health Award to H.M. King Bhumibol of Thailand for his work in the prevention and treatment of chest diseases in Thailand, was an unforgettable experience.
My presidential year ended in San Francisco. Since that time, my professional life has been varied and interesting. I was fortunate to continue my academic career encompassing both clinical and basic research. In 2005, I tried a new path and worked for the FDA Center for Devices and Radiological Health, using my background in device development (the angioscope) and clinical trials. Since 2012, I have been using my clinical, academic, and regulatory experience as an independent consultant in clinical trial design.
On a personal note, my partner of many years, Aymarah Robles, MD, FCCP, and I were finally able to marry in January 2015. So, we are now a happy and official two pulmonary, Cuban-American household enjoying the culture of Little Havana and the many outdoor activities of Miami!
Where are they now? What have they been up to? CHEST’s Past Presidents each forged the way for the many successes of the American College of Chest Physicians, leading to enhanced patient care around the globe. Their outstanding leadership and vision are evidenced today in many of CHEST’s strategic initiatives. Let’s check in with our first woman President, Dr. Deborah Shure.
Deborah Shure, MD, Master FCCP
President 1995-1996
When I began my year as President of the American College of Chest Physicians in 1995 in New York City, I became the first woman to serve in that role in the then 60-year history of the College. One major theme for my presidential year was inclusiveness. With the support of the Regents and the members of the College, we sought to increase the roles of our International Fellows and Affiliate Members, as well as the participation of all of our FCCPs. We also expanded the role of the College in global tobacco control.
With a focus on these goals, the presidential year was truly an exciting and fulfilling one. I was honored to meet so many members worldwide and, through the College, enable the support of regional meetings internationally. Our efforts in the Asia-Pacific area lent essential support to one of the early conferences on tobacco control in the Philippines (Asia Pacific Conference on Control of Tobacco, Subic, Philippines, 1998). My presentation in 1996 in Bangkok was the College’s first International Partnering for World Health Award to H.M. King Bhumibol of Thailand for his work in the prevention and treatment of chest diseases in Thailand, was an unforgettable experience.
My presidential year ended in San Francisco. Since that time, my professional life has been varied and interesting. I was fortunate to continue my academic career encompassing both clinical and basic research. In 2005, I tried a new path and worked for the FDA Center for Devices and Radiological Health, using my background in device development (the angioscope) and clinical trials. Since 2012, I have been using my clinical, academic, and regulatory experience as an independent consultant in clinical trial design.
On a personal note, my partner of many years, Aymarah Robles, MD, FCCP, and I were finally able to marry in January 2015. So, we are now a happy and official two pulmonary, Cuban-American household enjoying the culture of Little Havana and the many outdoor activities of Miami!
Where are they now? What have they been up to? CHEST’s Past Presidents each forged the way for the many successes of the American College of Chest Physicians, leading to enhanced patient care around the globe. Their outstanding leadership and vision are evidenced today in many of CHEST’s strategic initiatives. Let’s check in with our first woman President, Dr. Deborah Shure.
Deborah Shure, MD, Master FCCP
President 1995-1996
When I began my year as President of the American College of Chest Physicians in 1995 in New York City, I became the first woman to serve in that role in the then 60-year history of the College. One major theme for my presidential year was inclusiveness. With the support of the Regents and the members of the College, we sought to increase the roles of our International Fellows and Affiliate Members, as well as the participation of all of our FCCPs. We also expanded the role of the College in global tobacco control.
With a focus on these goals, the presidential year was truly an exciting and fulfilling one. I was honored to meet so many members worldwide and, through the College, enable the support of regional meetings internationally. Our efforts in the Asia-Pacific area lent essential support to one of the early conferences on tobacco control in the Philippines (Asia Pacific Conference on Control of Tobacco, Subic, Philippines, 1998). My presentation in 1996 in Bangkok was the College’s first International Partnering for World Health Award to H.M. King Bhumibol of Thailand for his work in the prevention and treatment of chest diseases in Thailand, was an unforgettable experience.
My presidential year ended in San Francisco. Since that time, my professional life has been varied and interesting. I was fortunate to continue my academic career encompassing both clinical and basic research. In 2005, I tried a new path and worked for the FDA Center for Devices and Radiological Health, using my background in device development (the angioscope) and clinical trials. Since 2012, I have been using my clinical, academic, and regulatory experience as an independent consultant in clinical trial design.
On a personal note, my partner of many years, Aymarah Robles, MD, FCCP, and I were finally able to marry in January 2015. So, we are now a happy and official two pulmonary, Cuban-American household enjoying the culture of Little Havana and the many outdoor activities of Miami!
It Will Be a Magical PAC Reception
SVS Past President Peter Gloviczki, MD, will perform his award-winning magic as the special guest at the SVS Political Action Committee (PAC) reception during the Vascular Annual Meeting.
All SVS members who have contributed to the PAC since January 2016 – including those who donate during VAM ‘17 -- are invited.
(The SVS PAC booth will be located outside the hall hosting the plenary sessions.)
Contributions can be made by mail with a personal check using the PAC donation form [PDF] or by credit/debit card at www.vascular.org/pac-donation. All SVS members who contribute to the PAC will receive pins, be recognized at the 2017 VAM and in the PAC Annual Report, in addition to being invited to the reception.
All PAC contributions are used to gain access to Congressional members and non-incumbent candidates in both political parties who make decisions about our issues. Although SVS has achieved many legislative victories, such as the repeal of the Sustainable Growth Rate formula that determined Medicare reimbursement, we have important issues to support/oppose. These include repealing the Independent Payment Advisory Board and preventing Medicare and imaging cuts.
SVS Past President Peter Gloviczki, MD, will perform his award-winning magic as the special guest at the SVS Political Action Committee (PAC) reception during the Vascular Annual Meeting.
All SVS members who have contributed to the PAC since January 2016 – including those who donate during VAM ‘17 -- are invited.
(The SVS PAC booth will be located outside the hall hosting the plenary sessions.)
Contributions can be made by mail with a personal check using the PAC donation form [PDF] or by credit/debit card at www.vascular.org/pac-donation. All SVS members who contribute to the PAC will receive pins, be recognized at the 2017 VAM and in the PAC Annual Report, in addition to being invited to the reception.
All PAC contributions are used to gain access to Congressional members and non-incumbent candidates in both political parties who make decisions about our issues. Although SVS has achieved many legislative victories, such as the repeal of the Sustainable Growth Rate formula that determined Medicare reimbursement, we have important issues to support/oppose. These include repealing the Independent Payment Advisory Board and preventing Medicare and imaging cuts.
SVS Past President Peter Gloviczki, MD, will perform his award-winning magic as the special guest at the SVS Political Action Committee (PAC) reception during the Vascular Annual Meeting.
All SVS members who have contributed to the PAC since January 2016 – including those who donate during VAM ‘17 -- are invited.
(The SVS PAC booth will be located outside the hall hosting the plenary sessions.)
Contributions can be made by mail with a personal check using the PAC donation form [PDF] or by credit/debit card at www.vascular.org/pac-donation. All SVS members who contribute to the PAC will receive pins, be recognized at the 2017 VAM and in the PAC Annual Report, in addition to being invited to the reception.
All PAC contributions are used to gain access to Congressional members and non-incumbent candidates in both political parties who make decisions about our issues. Although SVS has achieved many legislative victories, such as the repeal of the Sustainable Growth Rate formula that determined Medicare reimbursement, we have important issues to support/oppose. These include repealing the Independent Payment Advisory Board and preventing Medicare and imaging cuts.
Save $100: Pre-Purchase VAM On-Demand Library
VAM17 promises to keep you busy. Don't miss a moment. If you miss an event in your schedule, you can "attend" almost 400 individual presentations later by buying the On-Demand Library, featuring VAM PowerPoint slides, audio and a selection of videotaped sessions, all for the pre-event price of $99. The cost will increase after VAM ends.
This valuable resource will be available for one year, starting shortly after the meeting’s conclusion. If you already registered, no worries. Just return to the registration page and add the library separately.
VAM17 promises to keep you busy. Don't miss a moment. If you miss an event in your schedule, you can "attend" almost 400 individual presentations later by buying the On-Demand Library, featuring VAM PowerPoint slides, audio and a selection of videotaped sessions, all for the pre-event price of $99. The cost will increase after VAM ends.
This valuable resource will be available for one year, starting shortly after the meeting’s conclusion. If you already registered, no worries. Just return to the registration page and add the library separately.
VAM17 promises to keep you busy. Don't miss a moment. If you miss an event in your schedule, you can "attend" almost 400 individual presentations later by buying the On-Demand Library, featuring VAM PowerPoint slides, audio and a selection of videotaped sessions, all for the pre-event price of $99. The cost will increase after VAM ends.
This valuable resource will be available for one year, starting shortly after the meeting’s conclusion. If you already registered, no worries. Just return to the registration page and add the library separately.
Attend Aortic Summit at VAM 2017
This year’s Vascular Annual Meeting includes an important final-day summit on a number of factors in thoracoabdominal aneurysms and aortic disease.
The Society of Thoracic Surgeons is co-hosting the SVS/STS Summit, "Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection,” set for 1:30 to 5:15 p.m. Saturday, June 3.
Attendeeswill learn the technical aspects of both open and endovascular repair of thoracoabdominal aneurysms, to compare and contrast options for preservation of spinal cord function and identify current and future treatment options in the arena of Thoracic Endovascular Aneurysm Repair (TEVAR), focusing on aortic dissection.
The summit includes:
- A debate on the merits of medical versus endovascular treatment of uncomplicated dissections
- Training future cardiovascular surgeons to manage complex aortic disease
- Why thoracic and vascular surgeons will need to work together as open and endovascular experts to manage complex aortic disease
Sign up for the summit while registering for VAM. If you have already registered, simply return to the registration page and add the summit separately.
This year’s Vascular Annual Meeting includes an important final-day summit on a number of factors in thoracoabdominal aneurysms and aortic disease.
The Society of Thoracic Surgeons is co-hosting the SVS/STS Summit, "Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection,” set for 1:30 to 5:15 p.m. Saturday, June 3.
Attendeeswill learn the technical aspects of both open and endovascular repair of thoracoabdominal aneurysms, to compare and contrast options for preservation of spinal cord function and identify current and future treatment options in the arena of Thoracic Endovascular Aneurysm Repair (TEVAR), focusing on aortic dissection.
The summit includes:
- A debate on the merits of medical versus endovascular treatment of uncomplicated dissections
- Training future cardiovascular surgeons to manage complex aortic disease
- Why thoracic and vascular surgeons will need to work together as open and endovascular experts to manage complex aortic disease
Sign up for the summit while registering for VAM. If you have already registered, simply return to the registration page and add the summit separately.
This year’s Vascular Annual Meeting includes an important final-day summit on a number of factors in thoracoabdominal aneurysms and aortic disease.
The Society of Thoracic Surgeons is co-hosting the SVS/STS Summit, "Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection,” set for 1:30 to 5:15 p.m. Saturday, June 3.
Attendeeswill learn the technical aspects of both open and endovascular repair of thoracoabdominal aneurysms, to compare and contrast options for preservation of spinal cord function and identify current and future treatment options in the arena of Thoracic Endovascular Aneurysm Repair (TEVAR), focusing on aortic dissection.
The summit includes:
- A debate on the merits of medical versus endovascular treatment of uncomplicated dissections
- Training future cardiovascular surgeons to manage complex aortic disease
- Why thoracic and vascular surgeons will need to work together as open and endovascular experts to manage complex aortic disease
Sign up for the summit while registering for VAM. If you have already registered, simply return to the registration page and add the summit separately.
VRIC is May 3; Register Today
Register today for the May 3 Vascular Research Initiatives Conference.
The one-day meeting emphasizes emerging vascular science. It is considered a key event for meeting and reconnecting with vascular research collaborators.
New this year is the Alexander W. Clowes Distinguished Lecture, honoring the legacy of vascular surgeon-scientist Alec Clowes, M.D. William Sessa, Ph.D., of Yale University School of Medicine, will deliver the inaugural lecture, titled, "New Insights in Arteriogenesis and Blood Flow Control." The translational panel will discuss "Matrix Revolution: Vascular Repair and Regeneration," in a session co-sponsored with the International Society for Applied Cardiovascular Biology.
Four abstract sessions will focus on vascular endothelium and thrombosis, aortic and arterial pathology, stem cells and tissue engineering, and peripheral arterial disease. See the full program here.
Register today for the May 3 Vascular Research Initiatives Conference.
The one-day meeting emphasizes emerging vascular science. It is considered a key event for meeting and reconnecting with vascular research collaborators.
New this year is the Alexander W. Clowes Distinguished Lecture, honoring the legacy of vascular surgeon-scientist Alec Clowes, M.D. William Sessa, Ph.D., of Yale University School of Medicine, will deliver the inaugural lecture, titled, "New Insights in Arteriogenesis and Blood Flow Control." The translational panel will discuss "Matrix Revolution: Vascular Repair and Regeneration," in a session co-sponsored with the International Society for Applied Cardiovascular Biology.
Four abstract sessions will focus on vascular endothelium and thrombosis, aortic and arterial pathology, stem cells and tissue engineering, and peripheral arterial disease. See the full program here.
Register today for the May 3 Vascular Research Initiatives Conference.
The one-day meeting emphasizes emerging vascular science. It is considered a key event for meeting and reconnecting with vascular research collaborators.
New this year is the Alexander W. Clowes Distinguished Lecture, honoring the legacy of vascular surgeon-scientist Alec Clowes, M.D. William Sessa, Ph.D., of Yale University School of Medicine, will deliver the inaugural lecture, titled, "New Insights in Arteriogenesis and Blood Flow Control." The translational panel will discuss "Matrix Revolution: Vascular Repair and Regeneration," in a session co-sponsored with the International Society for Applied Cardiovascular Biology.
Four abstract sessions will focus on vascular endothelium and thrombosis, aortic and arterial pathology, stem cells and tissue engineering, and peripheral arterial disease. See the full program here.
Get Reduced Pricing Now for VAM On-Demand Library at VAM Registration
Don't forget you can take the Vascular Annual Meeting home with you! You can pre-purchase all VAM PowerPoint slides, audio and a limited selection of assorted videotaped sessions in the On-Demand Library. Purchase price through the conclusion of VAM (5 p.m. Saturday, June 3) is just $99.
This valuable resource of almost 400 individual presentations will be available shortly following the meeting’s conclusion, with access continued for up to one year.
The cost increases for VAM attendees after the meeting’s to $199, so buy now and save. For those who have already registered and now want to add the On-Demand Library, simply return to the registration page and add the library separately.
Register here for VAM and make housing reservations here.
Don't forget you can take the Vascular Annual Meeting home with you! You can pre-purchase all VAM PowerPoint slides, audio and a limited selection of assorted videotaped sessions in the On-Demand Library. Purchase price through the conclusion of VAM (5 p.m. Saturday, June 3) is just $99.
This valuable resource of almost 400 individual presentations will be available shortly following the meeting’s conclusion, with access continued for up to one year.
The cost increases for VAM attendees after the meeting’s to $199, so buy now and save. For those who have already registered and now want to add the On-Demand Library, simply return to the registration page and add the library separately.
Register here for VAM and make housing reservations here.
Don't forget you can take the Vascular Annual Meeting home with you! You can pre-purchase all VAM PowerPoint slides, audio and a limited selection of assorted videotaped sessions in the On-Demand Library. Purchase price through the conclusion of VAM (5 p.m. Saturday, June 3) is just $99.
This valuable resource of almost 400 individual presentations will be available shortly following the meeting’s conclusion, with access continued for up to one year.
The cost increases for VAM attendees after the meeting’s to $199, so buy now and save. For those who have already registered and now want to add the On-Demand Library, simply return to the registration page and add the library separately.
Register here for VAM and make housing reservations here.
Flashback to 2011
Barrett’s esophagus, named after Australian-born thoracic surgeon Norman Barrett in the 1950s, is now recognized as an important risk factor for esophageal adenocarcinoma. Estimating the magnitude of this risk has proved challenging; however, as early studies of Barrett’s esophagus tended to overestimate cancer risk because of small sample sizes and selection bias. Accurate risk estimation has profound implications for whether and how to identify and monitor patients with Barrett’s esophagus as part of a cancer-prevention strategy.
The December 2011 issue of GI & Hepatology News highlighted an influential study by Frederik Hvid-Jensen and his colleagues from Aarhus (Denmark) University that harnessed the power of Danish population-based registries to estimate the incidence of esophageal adenocarcinoma and high-grade dysplasia among patients with Barrett’s esophagus. Published in the New England Journal of Medicine (2011;365:1375-83), the study utilized data from Denmark’s national pathology and cancer registries to calculate the incidence of adenocarcinoma among patients with Barrett’s esophagus, compared with the general population. The study was unique in that there was nearly no loss to follow-up and no referral bias because of the nature of the registry.
Megan A. Adams, MD, JD, MSc, is a general gastroenterologist at Veterans Affairs, an investigator in the VA Center for Clinical Management Research, and a lecturer in gastroenterology at the University of Michigan, all in Ann Arbor. She currently serves as chair-elect of the AGA Quality Measures Committee and is an associate editor of GI & Hepatology News.
Barrett’s esophagus, named after Australian-born thoracic surgeon Norman Barrett in the 1950s, is now recognized as an important risk factor for esophageal adenocarcinoma. Estimating the magnitude of this risk has proved challenging; however, as early studies of Barrett’s esophagus tended to overestimate cancer risk because of small sample sizes and selection bias. Accurate risk estimation has profound implications for whether and how to identify and monitor patients with Barrett’s esophagus as part of a cancer-prevention strategy.
The December 2011 issue of GI & Hepatology News highlighted an influential study by Frederik Hvid-Jensen and his colleagues from Aarhus (Denmark) University that harnessed the power of Danish population-based registries to estimate the incidence of esophageal adenocarcinoma and high-grade dysplasia among patients with Barrett’s esophagus. Published in the New England Journal of Medicine (2011;365:1375-83), the study utilized data from Denmark’s national pathology and cancer registries to calculate the incidence of adenocarcinoma among patients with Barrett’s esophagus, compared with the general population. The study was unique in that there was nearly no loss to follow-up and no referral bias because of the nature of the registry.
Megan A. Adams, MD, JD, MSc, is a general gastroenterologist at Veterans Affairs, an investigator in the VA Center for Clinical Management Research, and a lecturer in gastroenterology at the University of Michigan, all in Ann Arbor. She currently serves as chair-elect of the AGA Quality Measures Committee and is an associate editor of GI & Hepatology News.
Barrett’s esophagus, named after Australian-born thoracic surgeon Norman Barrett in the 1950s, is now recognized as an important risk factor for esophageal adenocarcinoma. Estimating the magnitude of this risk has proved challenging; however, as early studies of Barrett’s esophagus tended to overestimate cancer risk because of small sample sizes and selection bias. Accurate risk estimation has profound implications for whether and how to identify and monitor patients with Barrett’s esophagus as part of a cancer-prevention strategy.
The December 2011 issue of GI & Hepatology News highlighted an influential study by Frederik Hvid-Jensen and his colleagues from Aarhus (Denmark) University that harnessed the power of Danish population-based registries to estimate the incidence of esophageal adenocarcinoma and high-grade dysplasia among patients with Barrett’s esophagus. Published in the New England Journal of Medicine (2011;365:1375-83), the study utilized data from Denmark’s national pathology and cancer registries to calculate the incidence of adenocarcinoma among patients with Barrett’s esophagus, compared with the general population. The study was unique in that there was nearly no loss to follow-up and no referral bias because of the nature of the registry.
Megan A. Adams, MD, JD, MSc, is a general gastroenterologist at Veterans Affairs, an investigator in the VA Center for Clinical Management Research, and a lecturer in gastroenterology at the University of Michigan, all in Ann Arbor. She currently serves as chair-elect of the AGA Quality Measures Committee and is an associate editor of GI & Hepatology News.
Support talented investigators through the AGA Research Foundation
Thanks to the generosity of our donors, the AGA Research Foundation is cultivating the future of the GI community through research grants to talented investigators. The work and discoveries of AGA-funded recipients will open doors to new treatments and exciting new areas of knowledge.
The foundation has a proven track record of investing in researchers whose work has helped shape the field of gastroenterology. With your support, we are building a community of investigators. Here are just a few of the researchers the AGA Research Foundation is funding.
Silvia Affo, PhD
Columbia University
2017 AGA Research Scholar Award Recipient
“I am extremely grateful to be selected for this award. I would like to thank the AGA Research Foundation and foundation donors for their generous support. This award will help me to build a research program to better understand mechanisms that promote the growth of cholangiocarcinoma.” – Dr. Affo will use this research funding to address the role of cancer-associated fibroblasts in cholangiocarcinoma using novel research tools.
Gary Wu, MD
University of Pennsylvania
2017 AGA-Dannon Gut Microbiome in Health Award
“I am deeply honored to be the recipient of this award. The resources provided by this award will allow us to investigate models for small molecule generation by the gut microbiota that influence the plasma metabolome of the host. These models will be particularly important to understand the manner by which diet serves as a substrate for the gut microbiota to produce metabolites that ultimately have an impact on human health.” – Dr. Wu will use this research initiative grant to support his team’s continued exploration into the microbiome, which will have tremendous impact on the future of health care.
Jose Saenz, MD, PhD
Washington University School of Medicine
2017 AGA–Gastric Cancer Foundation Research Scholar Award in Gastric Cancer
“I am honored to be a recipient of this award. I would like to thank the AGA for their generous contribution that will fund a crucial transition in my career. I would equally like to thank the various mentors that have guided me through this process and have provided invaluable advice in pursuit of my goals. This award will provide support to further understand the host-microbial interactions that characterize Helicobacter pylori’s regional and glandular colonization of the stomach.” – Dr. Saenz notes that this award represents a commitment to studying early events in the preneoplastic cascade toward gastric adenocarcinoma, one of the leading causes of cancer-related deaths worldwide.
Donate today to help us continue to protect the GI research pipeline. Make a tax-deductible donation at www.gastro.org/donateonline.
Thanks to the generosity of our donors, the AGA Research Foundation is cultivating the future of the GI community through research grants to talented investigators. The work and discoveries of AGA-funded recipients will open doors to new treatments and exciting new areas of knowledge.
The foundation has a proven track record of investing in researchers whose work has helped shape the field of gastroenterology. With your support, we are building a community of investigators. Here are just a few of the researchers the AGA Research Foundation is funding.
Silvia Affo, PhD
Columbia University
2017 AGA Research Scholar Award Recipient
“I am extremely grateful to be selected for this award. I would like to thank the AGA Research Foundation and foundation donors for their generous support. This award will help me to build a research program to better understand mechanisms that promote the growth of cholangiocarcinoma.” – Dr. Affo will use this research funding to address the role of cancer-associated fibroblasts in cholangiocarcinoma using novel research tools.
Gary Wu, MD
University of Pennsylvania
2017 AGA-Dannon Gut Microbiome in Health Award
“I am deeply honored to be the recipient of this award. The resources provided by this award will allow us to investigate models for small molecule generation by the gut microbiota that influence the plasma metabolome of the host. These models will be particularly important to understand the manner by which diet serves as a substrate for the gut microbiota to produce metabolites that ultimately have an impact on human health.” – Dr. Wu will use this research initiative grant to support his team’s continued exploration into the microbiome, which will have tremendous impact on the future of health care.
Jose Saenz, MD, PhD
Washington University School of Medicine
2017 AGA–Gastric Cancer Foundation Research Scholar Award in Gastric Cancer
“I am honored to be a recipient of this award. I would like to thank the AGA for their generous contribution that will fund a crucial transition in my career. I would equally like to thank the various mentors that have guided me through this process and have provided invaluable advice in pursuit of my goals. This award will provide support to further understand the host-microbial interactions that characterize Helicobacter pylori’s regional and glandular colonization of the stomach.” – Dr. Saenz notes that this award represents a commitment to studying early events in the preneoplastic cascade toward gastric adenocarcinoma, one of the leading causes of cancer-related deaths worldwide.
Donate today to help us continue to protect the GI research pipeline. Make a tax-deductible donation at www.gastro.org/donateonline.
Thanks to the generosity of our donors, the AGA Research Foundation is cultivating the future of the GI community through research grants to talented investigators. The work and discoveries of AGA-funded recipients will open doors to new treatments and exciting new areas of knowledge.
The foundation has a proven track record of investing in researchers whose work has helped shape the field of gastroenterology. With your support, we are building a community of investigators. Here are just a few of the researchers the AGA Research Foundation is funding.
Silvia Affo, PhD
Columbia University
2017 AGA Research Scholar Award Recipient
“I am extremely grateful to be selected for this award. I would like to thank the AGA Research Foundation and foundation donors for their generous support. This award will help me to build a research program to better understand mechanisms that promote the growth of cholangiocarcinoma.” – Dr. Affo will use this research funding to address the role of cancer-associated fibroblasts in cholangiocarcinoma using novel research tools.
Gary Wu, MD
University of Pennsylvania
2017 AGA-Dannon Gut Microbiome in Health Award
“I am deeply honored to be the recipient of this award. The resources provided by this award will allow us to investigate models for small molecule generation by the gut microbiota that influence the plasma metabolome of the host. These models will be particularly important to understand the manner by which diet serves as a substrate for the gut microbiota to produce metabolites that ultimately have an impact on human health.” – Dr. Wu will use this research initiative grant to support his team’s continued exploration into the microbiome, which will have tremendous impact on the future of health care.
Jose Saenz, MD, PhD
Washington University School of Medicine
2017 AGA–Gastric Cancer Foundation Research Scholar Award in Gastric Cancer
“I am honored to be a recipient of this award. I would like to thank the AGA for their generous contribution that will fund a crucial transition in my career. I would equally like to thank the various mentors that have guided me through this process and have provided invaluable advice in pursuit of my goals. This award will provide support to further understand the host-microbial interactions that characterize Helicobacter pylori’s regional and glandular colonization of the stomach.” – Dr. Saenz notes that this award represents a commitment to studying early events in the preneoplastic cascade toward gastric adenocarcinoma, one of the leading causes of cancer-related deaths worldwide.
Donate today to help us continue to protect the GI research pipeline. Make a tax-deductible donation at www.gastro.org/donateonline.
AGA tools help GIs manage patients with obesity
Patients with obesity need a multidisciplinary approach to achieve a healthy weight. AGA understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity led by gastroenterologists.
To watch
AGA Solutions to Successful Obesity Program Integration: Andres Acosta, MD, PhD, assistant professor in medicine, clinical enteric neuroscience translational and epidemiological research, division of gastroenterology and hepatology, Mayo Clinic, Rochester, MN, and Sarah Streett, MD, AGAF, clinical associate professor and director of IBD, Stanford (Calif.) University, discuss the AGA Obesity Guide and how GIs can begin to implement the program in their practices. Watch the on-demand webinar in the AGA Community resource library.
To read
POWER: Practice Guide on Obesity and Weight Management, Education and Resources: This practice guide on obesity and weight management will help you develop a multidisciplinary team and obesity care model for your practice.
Episode-of-Care Framework for the Management of Obesity: Moving toward high-value, high-quality care – AGA established an obesity episode-of-care model to develop a framework to support value-based management of patients with obesity, focusing on the provision of nonsurgical and endoscopic services.
These resources are available at www.gastro.org/obesity.
To discuss
Visit the AGA Community to join the discussion on managing your patient with obesity.
Patients with obesity need a multidisciplinary approach to achieve a healthy weight. AGA understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity led by gastroenterologists.
To watch
AGA Solutions to Successful Obesity Program Integration: Andres Acosta, MD, PhD, assistant professor in medicine, clinical enteric neuroscience translational and epidemiological research, division of gastroenterology and hepatology, Mayo Clinic, Rochester, MN, and Sarah Streett, MD, AGAF, clinical associate professor and director of IBD, Stanford (Calif.) University, discuss the AGA Obesity Guide and how GIs can begin to implement the program in their practices. Watch the on-demand webinar in the AGA Community resource library.
To read
POWER: Practice Guide on Obesity and Weight Management, Education and Resources: This practice guide on obesity and weight management will help you develop a multidisciplinary team and obesity care model for your practice.
Episode-of-Care Framework for the Management of Obesity: Moving toward high-value, high-quality care – AGA established an obesity episode-of-care model to develop a framework to support value-based management of patients with obesity, focusing on the provision of nonsurgical and endoscopic services.
These resources are available at www.gastro.org/obesity.
To discuss
Visit the AGA Community to join the discussion on managing your patient with obesity.
Patients with obesity need a multidisciplinary approach to achieve a healthy weight. AGA understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity led by gastroenterologists.
To watch
AGA Solutions to Successful Obesity Program Integration: Andres Acosta, MD, PhD, assistant professor in medicine, clinical enteric neuroscience translational and epidemiological research, division of gastroenterology and hepatology, Mayo Clinic, Rochester, MN, and Sarah Streett, MD, AGAF, clinical associate professor and director of IBD, Stanford (Calif.) University, discuss the AGA Obesity Guide and how GIs can begin to implement the program in their practices. Watch the on-demand webinar in the AGA Community resource library.
To read
POWER: Practice Guide on Obesity and Weight Management, Education and Resources: This practice guide on obesity and weight management will help you develop a multidisciplinary team and obesity care model for your practice.
Episode-of-Care Framework for the Management of Obesity: Moving toward high-value, high-quality care – AGA established an obesity episode-of-care model to develop a framework to support value-based management of patients with obesity, focusing on the provision of nonsurgical and endoscopic services.
These resources are available at www.gastro.org/obesity.
To discuss
Visit the AGA Community to join the discussion on managing your patient with obesity.
CHEST names Stephen J. Welch as EVP and CEO
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as executive vice president and chief executive officer.
“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP, in a statement.
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as executive vice president and chief executive officer.
“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP, in a statement.
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as executive vice president and chief executive officer.
“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP, in a statement.
